ALNY vs TRUP · P/E 76, rev $1.29B vs P/E 40, rev $777.0M
Alnylam Pharmaceuticals Inc (ALNY) versus Trupanion Inc (TRUP) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Trupanion Inc (TRUP) is a insurance - property & casualty company listed on NASDAQ.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported TRUP revenue for 2026-06-30 was $777.0M. TRUP currently screens at market cap $1.03B and trailing P/E 39.9.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. TRUP currently screens at market cap $1.03B and trailing P/E 39.9.
Not investment advice. Open the ALNY and TRUP stock pages for the full models.
Not investment advice.